Occudo Quantitative Strategies LP reduced its stake in shares of Trustmark Co. (NASDAQ:TRMK - Free Report) by 54.6% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 14,148 shares of the financial services provider's stock after selling 16,995 shares during the quarter. Occudo Quantitative Strategies LP's holdings in Trustmark were worth $500,000 as of its most recent SEC filing.
Other hedge funds also recently modified their holdings of the company. Barclays PLC grew its stake in Trustmark by 124.7% during the third quarter. Barclays PLC now owns 125,743 shares of the financial services provider's stock worth $4,001,000 after buying an additional 69,779 shares in the last quarter. Principal Financial Group Inc. lifted its holdings in shares of Trustmark by 6.8% during the 3rd quarter. Principal Financial Group Inc. now owns 598,969 shares of the financial services provider's stock worth $19,059,000 after acquiring an additional 37,989 shares during the period. JPMorgan Chase & Co. lifted its holdings in shares of Trustmark by 10.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 122,956 shares of the financial services provider's stock worth $3,912,000 after acquiring an additional 11,934 shares during the period. HB Wealth Management LLC boosted its position in shares of Trustmark by 0.7% during the 4th quarter. HB Wealth Management LLC now owns 74,634 shares of the financial services provider's stock worth $2,640,000 after acquiring an additional 528 shares in the last quarter. Finally, Blue Trust Inc. increased its stake in Trustmark by 19.0% in the fourth quarter. Blue Trust Inc. now owns 5,896 shares of the financial services provider's stock valued at $209,000 after acquiring an additional 943 shares during the last quarter. Institutional investors own 67.64% of the company's stock.
Trustmark Price Performance
Shares of TRMK traded up $0.05 during trading hours on Tuesday, reaching $36.02. The stock had a trading volume of 130,072 shares, compared to its average volume of 301,177. The company has a debt-to-equity ratio of 0.09, a quick ratio of 0.86 and a current ratio of 0.87. Trustmark Co. has a 12 month low of $27.42 and a 12 month high of $40.73. The stock has a market capitalization of $2.18 billion, a PE ratio of 9.89 and a beta of 0.63. The company's 50-day moving average is $33.80 and its two-hundred day moving average is $35.72.
Trustmark (NASDAQ:TRMK - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The financial services provider reported $0.88 EPS for the quarter, beating the consensus estimate of $0.82 by $0.06. Trustmark had a return on equity of 10.12% and a net margin of 19.42%. The firm had revenue of $231.83 million during the quarter, compared to the consensus estimate of $195.38 million. Research analysts expect that Trustmark Co. will post 3.42 EPS for the current year.
Trustmark Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Sunday, June 15th. Investors of record on Sunday, June 1st will be issued a $0.24 dividend. The ex-dividend date of this dividend is Friday, May 30th. This represents a $0.96 dividend on an annualized basis and a yield of 2.67%. Trustmark's dividend payout ratio (DPR) is presently 25.00%.
Wall Street Analysts Forecast Growth
Several research firms have weighed in on TRMK. Janney Montgomery Scott started coverage on Trustmark in a research note on Friday, January 24th. They set a "buy" rating and a $42.00 target price for the company. Hovde Group upped their price objective on Trustmark from $36.00 to $37.00 and gave the stock a "market perform" rating in a research report on Monday, April 28th. DA Davidson raised their price objective on Trustmark from $40.00 to $41.00 and gave the company a "neutral" rating in a research note on Thursday, January 30th. Finally, Keefe, Bruyette & Woods lowered their target price on Trustmark from $45.00 to $43.00 and set an "outperform" rating for the company in a research note on Thursday, April 24th. Four equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $39.80.
Get Our Latest Analysis on TRMK
Trustmark Profile
(
Free Report)
Trustmark Corporation operates as the bank holding company for Trustmark National Bank that provides banking and other financial solutions to individuals and corporate institutions in the United States. The company operates through three segments: General Banking, Wealth Management, and Insurance. It offers checking, savings, and money market accounts; certificates of deposits and individual retirement accounts; financing for commercial and industrial projects, income-producing commercial real estate, owner-occupied real estate, and construction and land development; and installment and real estate loans, and lines of credit, as well as treasury management services.
Read More
Before you consider Trustmark, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trustmark wasn't on the list.
While Trustmark currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
